Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBiogen Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 8 | $3.48 | $4.34 | $3.99 |
| Q2 2025 | 5 | $4.15 | $4.47 | $4.30 |
| Q3 2025 | 4 | $4.06 | $4.37 | $4.20 |
| Q4 2025 | 5 | $4.02 | $4.32 | $4.16 |
| Q1 2026 | 3 | $3.22 | $3.47 | $3.34 |
| Q2 2026 | 4 | $3.45 | $3.71 | $3.57 |
| Q3 2026 | 3 | $3.19 | $3.43 | $3.30 |
| Q4 2026 | 4 | $4.09 | $4.41 | $4.23 |
Biogen Inc. Earnings Date And Information
Biogen Inc. last posted its earnings results on Wednesday, October 30th, 2024. The company reported $4.08 earnings per share for the quarter, topping analysts' consensus estimates of $3.77 by $0.31. The company had revenue of 2.47 B for the quarter and had revenue of 9.84 B for the year. Biogen Inc. has generated $8 earnings per share over the last year ($7.97 diluted earnings per share) and currently has a price-to-earnings ratio of 13.81. Biogen Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 11th, 2025 based on prior year's report dates.
Biogen Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/30/2024 | Q3 2024 | $3.77 | $2.67 | -1.1 | $2.43 B | $2.47 B |
| 08/01/2024 | Q2 2024 | $4.07 | $4.01 | -0.06 | $2.39 B | $2.35 B |
| 04/24/2024 | Q1 2024 | $3.47 | $2.71 | -0.76 | $2.20 B | |
| 02/13/2024 | Q4 2023 | $3.16 | $1.72 | -1.44 | $2.39 B | |
| 11/08/2023 | Q3 2023 | $3.99 | -$0.47 | -4.46 | $2.40 B | $2.53 B |
| 07/25/2023 | Q2 2023 | $3.77 | $4.09 | 0.32 | $2.37 B | $2.46 B |
| 04/25/2023 | Q1 2023 | $3.28 | $2.69 | -0.59 | $2.46 B | |
| 02/15/2023 | Q4 2022 | $3.48 | $3.82 | 0.34 | $2.54 B | |
| 10/25/2022 | Q3 2022 | $4.13 | $7.86 | 3.73 | $2.47 B | $2.51 B |
| 07/20/2022 | Q2 2022 | $4.06 | $7.25 | 3.19 | $2.47 B | $2.59 B |
| 05/03/2022 | Q1 2022 | $4.41 | $1.51 | -2.9 | $2.53 B | |
| 02/03/2022 | Q4 2021 | $3.32 | $2.51 | -0.81 | $2.73 B | |
| 10/20/2021 | Q3 2021 | $4.15 | $2.22 | -1.93 | $2.67 B | $2.78 B |
| 07/22/2021 | Q2 2021 | $4.57 | $3.00 | -1.57 | $2.61 B | $2.78 B |
| 04/22/2021 | Q1 2021 | $5.06 | $2.70 | -2.36 | $2.69 B | |
| 02/03/2021 | Q4 2020 | $4.93 | $2.33 | -2.6 | $2.85 B | |
| 10/21/2020 | Q3 2020 | $8.06 | $4.47 | -3.59 | $3.33 B | $3.38 B |
| 07/22/2020 | Q2 2020 | $8.03 | $9.60 | 1.57 | $3.43 B | $3.68 B |
| 04/23/2020 | Q1 2020 | $8.10 | $3.53 B | |||
| 02/06/2020 | Q4 2019 | $8.10 | $3.67 B |
Biogen Inc. Earnings: FAQ's
When is Biogen Inc.'s earnings date?
Biogen Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 11th, 2025 based off last year's report dates.
Did Biogen Inc. beat their earnings estimates last
quarter?
In the previous quarter, Biogen Inc. (:BIIB) reported $4.08 earnings per share (EPS) to beat the analysts' consensus estimate of $3.77 by $0.31.
How can I listen to Biogen Inc.'s earnings conference
call?
The conference call for Biogen Inc.'s latest earnings report can be listened to online.
How can I read Biogen Inc.'s conference call transcript?
The conference call transcript for Biogen Inc.'s latest earnings report can be read online.
How much revenue does Biogen Inc. generate each year?
Biogen Inc. (:BIIB) has a recorded annual revenue of $9.84 B.
How much profit does Biogen Inc. generate each year?
Biogen Inc. (:BIIB) has a recorded net income of $9.84 B. Biogen Inc. has generated $8.02 earnings per share over the last four quarters.
What is Biogen Inc.'s price-to-earnings ratio?
Biogen Inc. (:BIIB) has a price-to-earnings ratio of 13.81 and price/earnings-to-growth ratio is 0.35.